Barriers to Adopting eClinical Solutions in Study Startup and Change Management

Barriers to Adopting eClinical Solutions in Study Startup and Change Management

The elimination of FUD

Innovation is often cited as the "key ingredient" by organizations striving to sustain an advantage in the increasingly competitive global marketplace. The pace of technology change is relentless, with those who don't embrace emerging trends often paying a hefty price. Simply "doing the same thing better", however, is not enough.

Technology adoption—particularly in highly regulated environments—is a complex issue that deserves careful thought and consideration. Innovation detractors comfortable with the 'status quo' often sow the seeds of fear, uncertainty, and doubt (FUD), which contributes to the technology risk aversion we see today in pharma.

Study startup is a complex, costly process that requires constant coordination across multiple stakeholders with enormous potential to save time and cut costs. Disrupting this process and reducing cycle times is not an incremental change. Perhaps, that is why it is so difficult and fraught with resistance by stakeholders and organizations alike.

But what are the barriers to adopting this innovative technology, and what change management practices are being utilized to ensure its successful adoption?

In this webinar, we will explore:

  • Challenges, barriers and opportunities involved in study startup related to processes, existing technology, data sharing, and operational transparency
  • Aspects associated with change management and assessment of technology deployments
  • Discussion on how leading organizations outrace their competition by outlearning them
  • Discussion on study startup technology and the importance of real-time metrics empowering business intelligence

This webinar is applicable to:

  • Sponsor and CRO roles responsible for site identification, feasibility assessment, selection and activation
  • Sponsor and CRO roles responsible for collecting trial documentation
  • Sponsor and CRO roles responsible for project management of studies and operational excellence

Presenters:

Andrew Schafer
Andrew is responsible for directing syndicated research products, custom market research efforts, and strategic planning. Prior to ISR, at Quintiles he was responsible for primary market research activities, leading strategy, functional service provider, and market development activities for data management and biostatistics, corporate new service introduction, and led the North American Corporate Strategy function. Andrew received undergraduate degrees in Finance and Economics and an MBA in Marketing and Statistics from Syracuse University.
ANDREW SCHAFER
President
Industry Standard Research
Elvin is a recognized industry expert in clinical trials, having over twenty years of experience working as a Clinical Business Analyst Consultant at major pharmaceutical companies including, Hoffmann-La Roche and Johnson & Johnson. Elvin works as a product strategist and system architect in goBalto’s effort to optimize Study Startup. Elvin is the co-chair on the TMF Reference Model Exchange Mechanism and holds a Master of Science in Industrial Engineering from Aalborg Universitet.
ELVIN THALUND
Senior Director, Industry Strategy
goBalto
Elvin Thalund

Need more information?

Contact us with your questions or to schedule a demo.